DOCSLIB.ORG

Effects of Nitrite and Nitroxyl on Human Vascular and Platelet Function

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Effects of Nitrite and Nitroxyl on Human Vascular and Platelet Function EFFECTS OF NITRITE AND NITROXYL ON HUMAN VASCULAR AND PLATELET FUNCTION Rustem Dautov MBBS (Hons), FRACP Department of Medicine, Faculty of Health Sciences University of Adelaide & Department of Cardiology, The Queen Elizabeth Hospital South Australia May 2014 A thesis submitted to the University of Adelaide as the requirement for the degree of Doctor of Philosophy Dedicated to my parents, my love Inara and children Zilya, Latipha and Temir ii Table of Contents Abstract!.............................................................................................................!x! Declaration!.......................................................................................................!xii! Publications, presentations and awards related to the work conducted towards this thesis!.........................................................................................................!xiii! Acknowledgements!...........................................................................................!xv! List of abbreviations!.......................................................................................!xvii! Chapter 1:! Introduction!.................................................................................!1! 1.1 Nitric oxide physiology!........................................................................................!2! 1.1.1 Introduction!.........................................................................................................!2! 1.1.2 Nitric oxide effects on vascular tone!...................................................................!2! 1.1.3 Nitric oxide production!.......................................................................................!4! 1.1.4 Nitric oxide diffusion!..........................................................................................!7! 1.1.5 Nitric oxide consumption!....................................................................................!7! 1.1.6 Molecular bases of NO action, including alternatives to direct activation of soluble guanylate cyclase!.............................................................................................!9! 1.1.7 Nitric oxide bioreactivity!.....................................................................................!9! 1.2 Nitric oxide pathophysiology: “endothelial dysfunction”!..................................!11! 1.2.1 Normal endothelial function!..............................................................................!11! 1.2.2 Endothelial dysfunction!.....................................................................................!12! 1.2.3 Clinical measurements of endothelial function!.................................................!13! 1.2.3.1 Invasive intra-coronary studies!................................................................................!14! 1.2.3.2 Assessment of endothelial function in peripheral vascular beds!..............................!15! 1.2.3.2.1!Venous!occlusion!plethysmography!................................................................!15! 1.2.3.2.2!Flow>mediated!vasodilatation!.........................................................................!16! 1.2.3.2.3!Pulse!wave!analysis!..........................................................................................!16! 1.2.3.2.4!Peripheral!arterial!tonometry!..........................................................................!17! 1.2.4 Biochemical assessment of endothelial function!...............................................!17! 1.2.5 Does arginine supplementation reverse endothelial dysfunction?!.....................!19! 1.2.6 Mechanism of endothelial dysfunction!..............................................................!19! iii 1.2.6.1 NO half-life and oxidative stress!.............................................................................!21! 1.2.6.2 Impaired nitric oxide synthesis: L-arginine and BH4 availability!............................!22! 1.2.6.3 Enhanced activity and expression of arginase!..........................................................!22! 1.2.6.4 Dysregulation of dimethylarginine dimethylaminohydrolase!..................................!23! 1.2.6.5 Reduced sensitivity to NO!.......................................................................................!23! 1.3 Nitric oxide resistance!.......................................................................................!23! 1.3.1 Introduction!.......................................................................................................!23! 1.3.2 Relationship between NO resistance and endothelial function!..........................!25! 1.3.3 Platelet function and NO resistance!...................................................................!26! 1.3.4 Epidemiology of NO resistance!.........................................................................!27! 1.3.5 Mechanisms of NO resistance!...........................................................................!29! 1.3.5.1 Nitric oxide bioavailability!......................................................................................!30! 1.3.5.2 Integrity of the NO/cGMP signaling pathway!.........................................................!31! 1.3.5.3 cGMP-independent effects of NO!............................................................................!33! 1.3.6 Prognostic value of NO resistance!.....................................................................!34! 1.3.7 Amelioration of NO resistance!..........................................................................!37! 1.3.7.1 Ascorbic acid!...........................................................................................................!37! 1.3.7.2 ACE inhibitors!.........................................................................................................!37! 1.3.7.3 Perhexiline!...............................................................................................................!38! 1.3.7.4 Glycaemic control!....................................................................................................!39! 1.3.7.5 Statins!......................................................................................................................!40! 1.3.8 Influence of thioredoxin-interacting protein (TXNIP) on NO signaling: implications regarding NO resistance and its amelioration!........................................!41! 1.4 Platelets: anatomy, physiology and pathophysiology!........................................!43! 1.4.1 Normal platelet function and anatomy!..............................................................!43! 1.4.2 Platelet adhesion!................................................................................................!45! 1.4.2.1 Von Willebrand Factor (vWf)!..................................................................................!45! 1.4.2.2 GP Ib-IX-V receptor complex!..................................................................................!45! 1.4.3 Platelet activation!..............................................................................................!46! 1.4.3.1 Platelet activation via ADP receptors!......................................................................!48! 1.4.3.2 Platelet activation via thrombin receptors!................................................................!48! 1.4.3.3 Platelet activation via thromboxane A2 receptors!....................................................!48! 1.4.4 Platelet aggregation!...........................................................................................!49! 1.4.5 Characterization of platelet aggregation!............................................................!49! 1.4.5.1 Platelet aggregometry!..............................................................................................!50! iv 1.4.5.1.1!Optical!platelet!aggregometry!.........................................................................!50! 1.4.5.1.2!Impedance!platelet!aggregometry!...................................................................!51! 1.4.5.1.3!The!rapid!platelet!function!analyzer!................................................................!51! 1.4.5.1.4!Shear>dependent!assay:!PFA>100!....................................................................!52! 1.4.5.2 Measures of platelet activation!................................................................................!52! 1.4.5.2.1!Soluble!platelet!activation!markers!.................................................................!52! 1.4.5.2.2!Flow!cytometry!................................................................................................!53! 1.5 Nitrate-Nitrite-Nitric oxide pathway!.................................................................!53! 1.5.1 Nitrogen living cycle!.........................................................................................!53! 1.5.2 Sources of nitric oxide!.......................................................................................!55! 1.5.3 Sources of nitrate and nitrite!..............................................................................!56! 1.5.4 Bioconversion of nitrate in the digestive tract!...................................................!57! 1.5.5 Nitrite bioactivation and hypoxic potentiation in humans!.................................!58! 1.5.5.1 Role of haemoglobin!................................................................................................!59! 1.5.5.2 Role of myoglobin!...................................................................................................!60!
Load more

Recommended publications
  • A Biochemical Rationale for the Discrete Behavior of Nitroxyl and Nitric Oxide in the Cardiovascular System
    A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system Katrina M. Miranda*†‡, Nazareno Paolocci§, Tatsuo Katori§, Douglas D. Thomas*, Eleonora Ford¶, Michael D. Bartbergerʈ, Michael G. Espey*, David A. Kass§, Martin Feelisch**, Jon M. Fukuto¶, and David A. Wink*† *Radiation Biology Branch, Building 10, Room B3-B69, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; §Division of Cardiology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD 21287; ¶Department of Molecular and Medical Pharmacology, Center for the Health Sciences, University of California, Los Angeles, CA 90095; ʈDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095; and **Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA 71130 Edited by Louis J. Ignarro, University of California School of Medicine, Los Angeles, CA, and approved May 20, 2003 (received for review February 20, 2003) The redox siblings nitroxyl (HNO) and nitric oxide (NO) have often cellular thiol functions (14, 15). Conversely, NO reacts only indi- been assumed to undergo casual redox reactions in biological sys- rectly with thiols after RNOS formation (17). tems. However, several recent studies have demonstrated distinct Contrasting effects are also apparent in vivo or ex vivo,for pharmacological effects for donors of these two species. Here, infu- example in models of ischemia reperfusion injury. Exposure to NO sion of the HNO donor Angeli’s salt into normal dogs resulted in donors at the onset of reperfusion provides protection against elevated plasma levels of calcitonin gene-related peptide, whereas reperfusion injury in the heart and other organs (18–20).
    [Show full text]
  • Increased Urinary Nitrate Excretion in Rats with Adjuvant Arthritis
    Annals of the Rheumatic Diseases 1994; 53: 547-549 547 Ann Rheum Dis: first published as 10.1136/ard.53.8.547 on 1 August 1994. Downloaded from Increased urinary nitrate excretion in rats with adjuvant arthritis Dirk 0 Stichtenoth, Frank-M Gutzki, Dimitrios Tsikas, Norma Selve, Stefanie M Bode-Boger, Rainer H Boger, Jurgen C Frolich Abstract well established model ofpolyarthritis. For this Objectives-In rats with adjuvant arthritis we applied a recently developed, highly spec measurements were taken of the urinary ific and sensitive gas chromatographic method excretion ofnitrate, reflecting endogenous for determination of nitrite and nitrate in nitric oxide (NO) formation, and cyclic serum, urine, synovia and cell supernatants. guanosine monophosphate (cGMP). NO itself is difficult to measure directly, Methods-Urinary nitrate was deter- because of its very short half life in biological mined by gas chromatography, cGMP by fluids. NO is readily oxidised to nitrite and radioimmunoassay. nitrate,7 which are excreted rapidly into urine. Results-A significant (p < 0.001), more It has been shown, that the major source of than three fold increase of urinary nitrate urinary nitrate, in the absence of excess nitrate excretion was found in rats 20 days after intake in food, is endogenously synthesised induction of adjuvant arthritis compared NO.8 Therefore the NO synthase activity can with non-arthritic rats. There was no be assessed reliably by measuring urinary significant difference in urinary cGMP nitrate excretion, as reported by Suzuki et al9 excretion between arthritic rats and and our group (Bode-Boger et al). control animals. Conclusion-The data suggest that the dramatic increase of urinary nitrate ex- Materials and methods cretion is due to increase of NO synthesis ANIMALS AND ARTHRITIS INDUCTION by the inducible form ofNO synthase.
    [Show full text]
  • Hidden Complexities in the Reaction of H2O2 and HNO Revealed by Ab Initio Quantum Chemical Cite This: Phys
    PCCP PAPER Hidden complexities in the reaction of H2O2 and HNO revealed by ab initio quantum chemical Cite this: Phys. Chem. Chem. Phys., 2017, 19, 29549 investigations† Daniel Beckett, Marc Edelmann, Jonathan D. Raff and Krishnan Raghavachari* Nitroxyl (HNO) and hydrogen peroxide have both been implicated in a variety of reactions relevant to environmental and physiological processes and may contribute to a unique, unexplored, pathway for the production of nitrous acid (HONO) in soil. To investigate the potential for this reaction, we report an in-depth investigation of the reaction pathway of H2O2 and HNO forming HONO and water. We find the breaking of the peroxide bond and a coupled proton transfer in the first step leads to hydrogen nitryl (HNO2) and an endogenous water, with an extrapolated NEVPT2 (multireference perturbation theory) barrier of 29.3 kcal molÀ1. The first transition state is shown to possess diradical character linking the far peroxide oxygen to the bridging, reacting, peroxide oxygen. The energy of this first step, when calculated using hybrid density functional theory, is shown to depend heavily on the amount of Hartree–Fock exchange in the functional, with higher amounts leading to a higher barrier and more diradical character. Additionally, high amounts of spin contamination cause CCSD(T) to significantly overestimate the TS1 barrier with a value of 36.2 kcal molÀ1 when using the stable UHF wavefunction as the reference wavefunction. However, when using the restricted Hartree–Fock reference wavefunction, the TS1 CCSD(T) energy is lowered to yield a barrier of 31.2 kcal molÀ1, in much better agreement with the Received 29th August 2017, NEVPT2 result.
    [Show full text]
  • Nitroaromatic Antibiotics As Nitrogen Oxide Sources
    Review biomolecules Nitroaromatic Antibiotics as Nitrogen Oxide Sources Review Allison M. Rice, Yueming Long and S. Bruce King * Nitroaromatic Antibiotics as Nitrogen Oxide Sources Department of Chemistry and Biochemistry, Wake Forest University, Winston-Salem, NC 27101, USA; Allison M. Rice , Yueming [email protected] and S. Bruce (A.M.R.); King [email protected] * (Y.L.) * Correspondence: [email protected]; Tel.: +1-336-702-1954 Department of Chemistry and Biochemistry, Wake Forest University, Winston-Salem, NC 27101, USA; [email protected]: Nitroaromatic (A.M.R.); [email protected] antibiotics (Y.L.) show activity against anaerobic bacteria and parasites, finding * Correspondence: [email protected]; Tel.: +1-336-702-1954 use in the treatment of Heliobacter pylori infections, tuberculosis, trichomoniasis, human African trypanosomiasis, Chagas disease and leishmaniasis. Despite this activity and a clear need for the Abstract: Nitroaromatic antibiotics show activity against anaerobic bacteria and parasites, finding usedevelopment in the treatment of new of Heliobacter treatments pylori forinfections, these conditio tuberculosis,ns, the trichomoniasis, associated toxicity human Africanand lack of clear trypanosomiasis,mechanisms of action Chagas have disease limited and their leishmaniasis. therapeutic Despite development. this activity Nitroaro and a clearmatic need antibiotics for require thereductive development bioactivation of new treatments for activity for theseand this conditions, reductive the associatedmetabolism toxicity can convert
    [Show full text]
  • Nitric Oxide Activates Guanylate Cyclase and Increases Guanosine 3':5'
    Proc. Natl. Acad. Sci. USA Vol. 74, No. 8, pp. 3203-3207, August 1977 Biochemistry Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations (nitro compounds/adenosine 3':5'-cyclic monophosphate/sodium nitroprusside/sodium azide/nitrogen oxides) WILLIAM P. ARNOLD, CHANDRA K. MITTAL, SHOJI KATSUKI, AND FERID MURAD Division of Clinical Pharmacology, Departments of Medicine, Pharmacology, and Anesthesiology, University of Virginia, Charlottesville, Virginia 22903 Communicated by Alfred Gilman, May 16, 1977 ABSTRACT Nitric oxide gas (NO) increased guanylate cy- tigation of this activation. NO activated all crude and partially clase [GTP pyrophosphate-yase (cyclizing), EC 4.6.1.21 activity purified guanylate cyclase preparations examined. It also in- in soluble and particulate preparations from various tissues. The effect was dose-dependent and was observed with all tissue creased cyclic GMP but not adenosine 3':5'-cyclic monophos- preparations examined. The extent of activation was variable phate (cyclic AMP) levels in incubations of minces from various among different tissue preparations and was greatest (19- to rat tissues. 33-fold) with supernatant fractions of homogenates from liver, lung, tracheal smooth muscle, heart, kidney, cerebral cortex, and MATERIALS AND METHODS cerebellum. Smaller effects (5- to 14-fold) were observed with supernatant fractions from skeletal muscle, spleen, intestinal Male Sprague-Dawley rats weighing 150-250 g were decapi- muscle, adrenal, and epididymal fat. Activation was also ob- tated. Tissues were rapidly removed, placed in cold 0.-25 M served with partially purified preparations of guanylate cyclase. sucrose/10 mM Tris-HCl buffer (pH 7.6), and homogenized Activation of rat liver supernatant preparations was augmented in nine volumes of this solution by using a glass homogenizer slightly with reducing agents, decreased with some oxidizing and Teflon pestle at 2-4°.
    [Show full text]
  • Nitroglycerin Sublingual Tablets, USP)
    NDA 021134/S-004 Page 4 Nitrostat® (Nitroglycerin Sublingual Tablets, USP) DESCRIPTION Nitrostat is a stabilized sublingual compressed nitroglycerin tablet that contains 0.3 mg , 0.4 mg , or 0.6 mg nitroglycerin; as well as lactose monohydrate, NF; glyceryl monostearate, NF; pregelatinized starch, NF; calcium stearate, NF powder; and silicon dioxide, colloidal, NF. Nitroglycerin, an organic nitrate, is a vasodilating agent. The chemical name for nitroglycerin is 1, 2, 3 propanetriol trinitrate and the chemical structure is: NO2 O O N O CH2CHCH2 O NO 2 2 C3H5N309 Molecular weight: 227.09 CLINICAL PHARMACOLOGY The principal pharmacological action of nitroglycerin is relaxation of vascular smooth muscle. Although venous effects predominate, nitroglycerin produces, in a dose-related manner, dilation of both arterial and venous beds. Dilation of postcapillary vessels, including large veins, promotes peripheral pooling of blood, decreases venous return to the heart, and reduces left ventricular end-diastolic pressure (preload). Nitroglycerin also produces arteriolar relaxation, thereby reducing peripheral vascular resistance and arterial pressure (afterload), and dilates large epicardial coronary arteries; however, the extent to which this latter effect contributes to the relief of exertional angina is unclear. Therapeutic doses of nitroglycerin may reduce systolic, diastolic, and mean arterial blood pressure. Effective coronary perfusion pressure is usually maintained, but can be compromised if blood pressure falls excessively, or increased heart rate decreases diastolic filling time. Elevated central venous and pulmonary capillary wedge pressures, and pulmonary and systemic vascular resistance are also reduced by nitroglycerin therapy. Heart rate is usually slightly increased, presumably due to a compensatory response to the fall in blood pressure.
    [Show full text]
  • Mechanisms of Nitric Oxide Reactions Mediated by Biologically Relevant Metal Centers
    Struct Bond (2014) 154: 99–136 DOI: 10.1007/430_2013_117 # Springer-Verlag Berlin Heidelberg 2013 Published online: 5 October 2013 Mechanisms of Nitric Oxide Reactions Mediated by Biologically Relevant Metal Centers Peter C. Ford, Jose Clayston Melo Pereira, and Katrina M. Miranda Abstract Here, we present an overview of mechanisms relevant to the formation and several key reactions of nitric oxide (nitrogen monoxide) complexes with biologically relevant metal centers. The focus will be largely on iron and copper complexes. We will discuss the applications of both thermal and photochemical methodologies for investigating such reactions quantitatively. Keywords Copper Á Heme models Á Hemes Á Iron Á Metalloproteins Á Nitric oxide Contents 1 Introduction .................................................................................. 101 2 Metal-Nitrosyl Bonding ..................................................................... 101 3 How Does the Coordinated Nitrosyl Affect the Metal Center? .. .. .. .. .. .. .. .. .. .. .. 104 4 The Formation and Decay of Metal Nitrosyls ............................................. 107 4.1 Some General Considerations ........................................................ 107 4.2 Rates of NO Reactions with Hemes and Heme Models ............................. 110 4.3 Mechanistic Studies of NO “On” and “Off” Reactions with Hemes and Heme Models ................................................................................. 115 4.4 Non-Heme Iron Complexes ..........................................................
    [Show full text]
  • Nitric Oxide.Vp
    CHAPTER 5 Maple Leaf Foods, Toronto, Canada Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX 77030 ESPITE the many published reports on the beneficial properties of Dnitrite and nitrate in physiology, nitrite and nitrate in cured and pro- cessed meats continues to be perceived as harmful. The previous chapter revealed that certain foods, particularly green leafy vegetables are natu- rally enriched in nitrite and nitrate from growing in soil. However, en- riching meats with nitrite or nitrate during curing is perceived as harmful and advocated by some groups to be eliminated completely. The use of pure sodium nitrate in curing is now only a minor practice in the United States. The ingoing levels of sodium nitrite have been tightly controlled by the Food Safety and Inspection Service (FSIS) of the U.S. Depart- ment of Agriculture. To satisfy consumer demands for no added nitrite processed meats, efforts have recently been taken to creatively adjust the meat curing process by employing “nitrite free” organic vegetable pow- ders instead of directly adding sodium nitrite salts. Although the end re- sult is production of nitrite from the nitrate contained in the vegetable powders, a more “natural” or “organic” approach seems to appeal to con- sumers. This is primarily due to the public perception of nitrite and ni- trate. Reports about methemoglobinemia in infants (blue baby syndrome) caused by drinks or food prepared with nitrate-rich (and bac- terially contaminated) well water and vegetables, intentional and occu- pational intoxications in adults, increasing nitrate levels in soil and lakes as a result of fertilizer overuse, and the formation of potentially carcino- genic N-nitrosamines all contribute to the negative image that nitrite and nitrate have held in recent years.
    [Show full text]
  • On the Distinction Between Nitroxyl and Nitric Oxide Using Nitronyl Nitroxides
    Published on Web 05/26/2010 On the Distinction between Nitroxyl and Nitric Oxide Using Nitronyl Nitroxides Uri Samuni,† Yuval Samuni,‡ and Sara Goldstein*,§ Department of Chemistry and Biochemistry, Queens College, City UniVersity of New York, Flushing, New York 11367, and Department of Prosthodontics, School of Dental Medicine, and Institute of Chemistry, The Accelerator Laboratory, The Hebrew UniVersity of Jerusalem, Jerusalem 91904, Israel Received March 8, 2010; E-mail: [email protected] Abstract: A better understanding of the origins of NO and HNO and their activities and biological functions requires accurate methods for their detection and quantification. The unique reaction of NO with nitronyl nitroxides such as 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (C-PTIO), which yields the corresponding imino nitroxides, is widely used for NO detection (mainly by electron paramagnetic resonance spectroscopy) and for modulation of NO-induced physiological functions. The present study demonstrates that HNO readily reacts with nitronyl nitroxides, leading to the formation of the respective imino nitroxides and hydroxylamines via a complex mechanism. Through the use of the HNO donor Angeli’s salt (AS) with metmyoglobin as a competing agent, the rate constant for C-PTIO reduction by HNO has been determined to be (1.4 ( 0.2) × 105 M-1 s-1 at pH 7.0. This reaction yields the corresponding nitronyl • hydroxylamine C-PTIO-H and NO, which is trapped by C-PTIO to form NO2 and the corresponding imino • nitroxide, C-PTI. NO2 oxidizes the nitronyl and imino nitroxides to their respective oxoammonium cations, which decay mainly via comproportionation with the nitronyl and imino hydroxylamines.
    [Show full text]
  • The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows
    molecules Review The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows Elli Zoupa and Nikolaos Pitsikas * Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Panepistimiou 3, 415-00 Larissa, Greece; [email protected] * Correspondence: [email protected]; Tel.: +30-2410-685535 Abstract: Schizophrenia is a severe psychiatric disorder affecting up to 1% of the worldwide popula- tion. Available therapy presents different limits comprising lack of efficiency in attenuating negative symptoms and cognitive deficits, typical features of schizophrenia and severe side effects. There is pressing requirement, therefore, to develop novel neuroleptics with higher efficacy and safety. Nitric oxide (NO), an intra- and inter-cellular messenger in the brain, appears to be implicated in the pathogenesis of schizophrenia. In particular, underproduction of this gaseous molecule is associated to this mental disease. The latter suggests that increment of nitrergic activity might be of utility for the medication of schizophrenia. Based on the above, molecules able to enhance NO production, as are NO donors, might represent a class of compounds candidates. Sodium nitroprusside (SNP) is a NO donor and is proposed as a promising novel compound for the treatment of schizophrenia. In the present review, we intended to critically assess advances in research of SNP for the therapy of schizophrenia and discuss its potential superiority over currently used neuroleptics. Citation: Zoupa, E.; Pitsikas, N. The Nitric Oxide (NO) Donor Sodium Keywords: schizophrenia; nitric oxide; sodium nitroprusside Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows.
    [Show full text]
  • An Endogenous Source of Elevated Nitrite in Infected Urine
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Kidney International, Vol. 45 (1994), pp. 586—591 Nitric oxide synthase: An endogenous source of elevated nitrite in infected urine SHANNON D. SMITH, MARCIA A. WHEELER, and ROBERT M. WEIss Section of Urology, Yale University School of Medicine, New Haven, Connecticut, USA Nitric oxide synthase: An endogenous source of elevated nitrite inwe measured both the nitrite concentration and nitric oxide infected urine. To further define the endogenous sources of urine nitrite in urinary tract infections, we measured urinary nitrite levels by the synthase activity in human infected and non-infected urine. Griess method and assayed urinary nitric oxide (NO) synthase activity by the conversion of '4C-arginine to '4C-citrulline. Endogenous produc- Methods tion of '4C-citrulline was confirmed by thin layer chromatography. Exogenous L-arginine increased nitrite production in whole infected Urine sample isolation urine, but not in bacteria isolated from infected urine. Urinary tract Urine specimens from symptomatic emergency room and infections significantly increased NO synthase activity in soluble urine fractions, although soluble activity was less than 10% of particulate urology clinic patients (N =18)were submitted to the Clinical activity. Urine particulate fractions from women with non-infectedMicrobiology Laboratory at the Yale-New Haven Hospital urine had greater NO synthase activity than particulate fractions from after routine urinalysis. The majority (87%) were clean-catch men with non-infected urine, 11 2and 0.2 0.1picomol/minlmg midstream specimens; the remainder (13%) were obtained by protein, respectively. Urinary tract infections increased NO synthase sterile catheterization.
    [Show full text]
  • Nitroxyl-Mediated Peroxide Modification of Polypropylene
    Nitroxyl-Mediated Peroxide Modification of Polypropylene by Benjamin Rhys Jones A thesis submitted to the Department of Chemical Engineering In conformity with the requirements for the degree of Master of Applied Science Queen’s University Kingston, Ontario, Canada (May 2021) Copyright ©Benjamin Rhys Jones, 2021 Abstract The thermal stability of alkoxyamine derivatives of polypropylene (PP) is examined through studies of model hydrocarbon systems and atactic-PP substrates. Primary, secondary and tertiary alkoxyamines are integral to modern techniques for modifying the architecture of linear PP materials, and detailed knowledge of their stability at polymer processing temperatures is needed to further understand the underlying principles of nitroxyl-based formulations. GC analysis of alkoxyamines derived from 2,4-dimethylpentane + TEMPO show that the tertiary regioisomer is susceptible to disproportionation to alkene + HOTEMPO at temperatures as low as 140 oC. Extension of these thermolysis experiments to atactic PP-g-HOTEMPO mirrored the model compound results, with appreciable extents of nitroxyl generation observed over a 20 min timescale at 180 oC. This reaction extent is not expected to dramatically alter the performance of nitroxyl-based formulations that modify the structure and composition of PP homopolymers. The yield of H-atom abstraction by peroxide-derived alkoxy radicals is another fundamental reaction that underlies polyolefin modifications. Indirect measures based on analysis of peroxide byproducts are supplemented with a fluorescence spectroscopy method that quantifies polymer- bound alkoxyamines. H-atom transfer from high density polyethylene (HDPE) and poly(ethylene-co-propylene) (EPR) was gained by using napthoyloxy-TEMPO, whose fluorophore supports a highly sensitive analytical method. This technique is extended to studies of reactive HDPE/EPR blending to ascertain the extent of peroxide migration from one phase to the other during the compounding process.
    [Show full text]